These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6545533)

  • 1. Structure-activity relationship studies of neuronal monoamine uptake inhibition of pyridylallylamines.
    Singh P
    Indian J Biochem Biophys; 1984 Dec; 21(6):406-8. PubMed ID: 6545533
    [No Abstract]   [Full Text] [Related]  

  • 2. The pseudoirreversible inhibition of monoamine oxidase by allylamine.
    Rando RR; Eigner A
    Mol Pharmacol; 1977 Nov; 13(6):1005-13. PubMed ID: 593260
    [No Abstract]   [Full Text] [Related]  

  • 3. [Amine binding with mitochondrial monoamine oxidase and the selective inhibition of enzymatic activity by pyridine derivatives].
    Severina IS; Kozlova IS
    Biokhimiia; 1973; 38(5):1076-82. PubMed ID: 4780966
    [No Abstract]   [Full Text] [Related]  

  • 4. (Z)-2-(2,4-Dichlorophenoxy)methyl-3-fluoroallylamine (MDL 72638): a clorgyline analogue with surprising selectivity for monoamine oxidase type B.
    McDonald IA; Palfreyman MG; Zreika M; Bey P
    Biochem Pharmacol; 1986 Jan; 35(2):349-51. PubMed ID: 3753647
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative ex vivo inhibitory effects of (E)-2-(3,4-dimethoxyphenyl)-3-fluoroallylamine (MDL 72145) on amine oxidase activities in the rat.
    Lyles GA; Marshall CM; Flucker CJ
    Biochem Pharmacol; 1989 Sep; 38(17):2937-40. PubMed ID: 2775316
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between chemical structure and pharmacologic activity of several new monoamine oxidase inhibitors].
    Boissier JR; Dumont C; Forest J
    Therapie; 1967; 22(2):367-73. PubMed ID: 6063424
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
    O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
    J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of monoamine oxidases with tertiary amines.
    Singer TP; Ramsay RR
    Biochem Soc Trans; 1991 Feb; 19(1):211-5. PubMed ID: 2037153
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues.
    Ross SB; Renyi AL
    Neuropharmacology; 1977 Jan; 16(1):57-63. PubMed ID: 834363
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of pyridylallylamines related to zimelidine and their inhibition of neuronal monoamine uptake.
    Högberg T; Ulff B; Renyi AL; Ross SB
    J Med Chem; 1981 Dec; 24(12):1499-507. PubMed ID: 6458703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR of inhibition of monoamine oxidase by substituted phenylalkylamines in vitro and in various neurons in vivo.
    Mahmoudian M
    Acta Pharm Suec; 1988; 25(3):151-62. PubMed ID: 3239401
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective inhibition of monoamine oxidase.
    Fuller RW
    Adv Biochem Psychopharmacol; 1972; 5():339-54. PubMed ID: 4559891
    [No Abstract]   [Full Text] [Related]  

  • 13. Inactivation of monoamine oxidase by allylamine does not result in flavin attachment.
    Silverman RB; Hiebert CK; Vazquez ML
    J Biol Chem; 1985 Nov; 260(27):14648-52. PubMed ID: 4055794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structure-action relations of monoamine oxidase inhibitors].
    Matthies H; Fähse C; Lietz W; Jassmann E
    Acta Biol Med Ger; 1967; 19(3):447-61. PubMed ID: 5591162
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoamine oxidase inhibitors.
    Ho BT
    J Pharm Sci; 1972 Jun; 61(6):821-37. PubMed ID: 4558257
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of platelet monamine oxidase inhibition during amitriptyline or zimelidine treatment.
    Reveley MA; Glover V; Slander M; Coppen A
    Br J Clin Pharmacol; 1979 Oct; 8(4):375-8. PubMed ID: 508514
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibition of monoamine oxidase activity by 2-N-acetylaminocyclohexene-2-one and related compounds].
    Ermolaev KM; Gridneva LI; Maĭmind VI; Gorkin VZ
    Vopr Med Khim; 1967; 13(3):286-90. PubMed ID: 5597204
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of some aliphatic amines on the activity of monoamine oxidase in rats].
    Valiev AG
    Farmakol Toksikol; 1968; 31(2):238-40. PubMed ID: 5674685
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitors of neuronal monoamine uptake. I. Selective inhibition of 5-hydroxytryptamine uptake by alpha-aminoacid amides of phenethylamines.
    Lindberg UH; Thorberg SO; Renyi AL; Ross SB; Ogren SO
    Acta Pharm Suec; 1978; 15(2):87-96. PubMed ID: 676761
    [No Abstract]   [Full Text] [Related]  

  • 20. [The influence of various psychopharmacologic agents on the phenelzine-induced increase of gamma-aminobutyric acid in the rat brain].
    Popov N; Rösler V; Matthies H
    Acta Biol Med Ger; 1967; 19(1):111-9. PubMed ID: 5301518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.